<SEC-DOCUMENT>0001493152-25-009567.txt : 20250407
<SEC-HEADER>0001493152-25-009567.hdr.sgml : 20250407
<ACCEPTANCE-DATETIME>20250307161515
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001493152-25-009567
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20250307

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMPACT BIOMEDICAL INC.
		CENTRAL INDEX KEY:			0001834105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				853926944
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		1400 BROADFIELD BLVD.
		STREET 2:		SUITE 130
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77084
		BUSINESS PHONE:		585 232 1500

	MAIL ADDRESS:	
		STREET 1:		1400 BROADFIELD BLVD.
		STREET 2:		SUITE 130
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77084
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><IMG SRC="formcorresp_001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    7, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Via
EDGAR</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Securities and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Division
of Corporation Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
of Life Sciences</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
F Street, N.E.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
D.C. 20549</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Ibolya Ignat / Ms. Angela Connell</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impact
    BioMedical, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impact
                                            BioMedical, INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
    10-K for the fiscal year ended December 31, 2023 Filed February 20, 2024</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
    10-Q for the quarter ended</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
    No. 001-42212</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Ms. Ignat and Ms. Connell:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
behalf of Impact BioMedical, INC. (the &ldquo;<B>Company</B>&rdquo;), we have set forth below responses to the comments of the staff
(the &ldquo;<B>Staff</B>&rdquo;) of the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) contained in its letter of
February 6, 2025, with respect to the Company&rsquo;s Annual Report on Form 10-K (the &ldquo;<B>Form 10-K</B>&rdquo;) and Quarterly Report
on Form 10-Q (the &ldquo;<B>Form 10-Q</B>&rdquo;) as noted above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
your convenience, the text of the Staff&rsquo;s comments is set forth below in bold, followed in each case by the Company&rsquo;s responses.
Please note that all references to page numbers in the responses are references to the page numbers in the Form 10-K a the Form 10-Q.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
10-Q for the Quarterly Period Ended September 30, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to the Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
7. Note payable, related party, page 12</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
We note your response to prior comment one. Your response does not address our request for an analysis under ASC 470-50-40. Accordingly,
we reissue this part of our comment. Specifically, please provide a robust analysis which explains how you evaluated the terms of the
Second Amended and Restated Promissory Note, which was effective September 16, 2024, to determine if the modification resulted in substantially
different terms which would result in extinguishment accounting. Refer to ASC 470-50-40-6 through 40-16.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Response:
</B>In response to the Staff&rsquo;s first question regarding Note 7 within the September 30, 2024, financial statements of the Company,
the Company respectfully advises the Staff to please see attached the memo written to support the accounting treatment, annexed hereto
as <U>Exhibit A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
AVENUE OF THE AMERICAS |  31ST FLOOR | NEW YORK, NY | 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">T (212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><IMG SRC="formcorresp_001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
In your response, you indicate that the instrument would not be considered freestanding and therefore not accounted for under ASC 480.
By &ldquo;instrument&rdquo;, it appears that you are referring to the option to settle your repayment obligation by issuing shares, which
you have referred to as a conversion option. It is unclear to us why your Note payable, related party, in its entirety, would not be
considered a freestanding financial instrument under ASC 480. Please advise. Please also explain your consideration of ASC 480-10-25-14(a)
which requires liability classification for an obligation to issue a variable number of shares provided that, at inception, the monetary
value of the obligation is based solely or predominantly on a fixed dollar amount. In this regard, we note that the September 2024 amendment
to the Promissory Note stipulates that any stock issued as payment under the Note should be based on a conversion ratio of $3 per share
during the first 12-month period and based on a 10-day volume-weighted average price (VWAP) thereafter. The amount of shares to be issued
to settle your repayment obligation would appear to vary after month 12 based on the volume-weighted average price of the company&rsquo;s
shares.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Response:
</B>In response to the Staff&rsquo;s second question regarding Note 7 within the September 30, 2024, financial statements of the Company,
the Company respectfully advises the Staff to please see attached the memo written to support the accounting treatment, annexed hereto
as <U>Exhibit B</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
In the event that you continue to believe that your Note payable, related party is not required to be accounted for as a liability at
fair value under ASC 480 but that such note will be remeasured at fair value pursuant to the election under ASC 815-15-25-4, please revise
to provide the disclosures required by ASC 825-10-50-28 through 50-32. Provide us with a draft of your intended disclosure revisions.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Response:
</B>In response to the Staff&rsquo;s third question regarding Note 7 within the September 30, 2024, financial statements of the Company,
the Company respectfully advises the Staff that the Company agrees with that the note should be accounted for under ASC 480 at fair value
(see memo at Exhibit B). Please see comments to question 4 below for further discussion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
As a related matter, you indicate in your response that the disclosure in your Form 10- Q incorrectly describes your accounting for your
Note payable, related party and the related embedded derivative, but that this error does not impact the amount reported in your financial
statements. Please address the following:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confirm
    whether you plan to amend your September 30, 2024 Form 10-Q to correct such disclosures.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Response:
    </B>In response to the Staff&rsquo;s fourth question, first bullet regarding Note 7 within the September 30, 2024, financial statements
    of the Company, Management does believe that the transaction is accurately accounted for within the Condensed Consolidated Balance
    Sheet, Condensed Consolidated Statement of Operations and Condensed Consolidated Statement of Cash Flows. However, upon further review
    of this disclosure, which illustrates a bifurcation of the embedded derivative, Management has determined that what was disclosed
    does not adequately depict the accounting treatment of the Note payable, related party. Although the disclosure in Note 7 does not
    adequately depict the accounting treatment, no restatement is deemed needed for the period ended September 30, 2024.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Provide
    us with a draft of the disclosures you intend to revise as it relates to the accounting for you Note payable, related party and the
    classification of the associated gain in your Statement of Operations.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Response:
    </B>In response to the Staff&rsquo;s fourth question, second bullet regarding Note 7 within the September 30, 2024, financial statements
    of the Company, please see Exhibit C for the footnote disclosure to be utilized within the December 31, 2024 10-K filing. Further,
    this Note will be identified as a Level 2 financial instrument within the Footnote 3 &ndash; Financial Instruments. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
AVENUE OF THE AMERICAS | 31ST FLOOR | NEW YORK, NY | 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">T (212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formcorresp_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>More
    clearly explain to us why the fair value of your Note payable, related party decreased from $12 million at December 31, 2023 to $8
    million at September 30, 2024 and what contributed to the gain of $5.7 million recognized in your Statement of Operations. In this
    regard, it appears that the outstanding principal balance as of September 30, 2024 s $12.9 million. </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Response:
    </B>In response to the Staff&rsquo;s fourth question, third bullet regarding Note 7 within the September 30, 2024, financial statements
    of the note in question at December 31, 2023 did not contain and optional repayment method via Company shares. The 2<SUP>nd</SUP>
    amendment to this note introduced this feature thus requiring a fair value analysis under ASC 825 to be performed, resulting in the
    gain recognized in the Statement of Operations. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
trust that the above is responsive to your comments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
you have any questions relating to the foregoing or wish to discuss any aspect of the Company&rsquo;s filing, please contact me at (212)
930-9700.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Darrin M. Ocasio</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Darrin
    M. Ocasio, Esq.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
    Ross Ference Carmel LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
AVENUE OF THE AMERICAS | 31ST FLOOR | NEW YORK, NY | 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">T (212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="exa_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MEMORANDUM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.75in"><B>To:</B></TD>
  <TD>Accounting files</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>&nbsp;</B></TD>
  <TD>&nbsp;</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>From:</B></TD>
  <TD>Todd D. Macko, CFO</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>&nbsp;</B></TD>
  <TD>&nbsp;</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>Date:</B></TD>
  <TD>December 31, 2024</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>&nbsp;</B></TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>CC:</B></TD>
  <TD>Grassi</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>&nbsp;</B></TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>Subject:</B></TD>
  <TD>Evaluation of Impact/DSS Loan Amendment Under ASC 470-50-40</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT><BR>
<BR></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2024, the Company entered into a loan agreement with the following key terms:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Original
Loan</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Start
                                            Date:</B> January 18, 2024</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maturity
                                            Date:</B> September 30, 2030</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interest
                                            Rate:</B> WSJ Prime + 0.5%</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
                                            Frequency:</B> Monthly</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
                                            Terms:</B> Interest-only payments through February 2026; principal and interest of $126,381
                                            thereafter</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>On-Demand
                                            Feature:</B> Yes</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
                                            Calculation:</B> Cash</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prepayment:
                                            </B>Allowed with no penalty</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 16, 2024 this loan was amended to include the following key terms:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Amended
Loan</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Start
                                            Date: </B>September 16, 2024</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maturity
                                            Date:</B> September 30, 2030</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interest
                                            Rate:</B> WSJ Prime + 0.5%</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
                                            Frequency:</B> Quarterly</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
                                            Terms:</B> Interest-only payments beginning December 31, 2024; principal and interest of
                                            $126,381 beginning October 2027</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>On-Demand
                                            Feature:</B> Yes, beginning September 2026</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
                                            Calculation:</B> Cash; optional stock payment at $3 per share for first 12 months and then
                                            10-day VWAP until maturity</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prepayment:
                                            </B>Allowed with no penalty</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal
                                            Increase:</B> Due to additional borrowings</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounting
Analysis Under ASC 470-50-40</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
470-50-40 provides guidance on debt modifications and extinguishments. Specifically, ASC 470-50-40-6 through ASC 470-50-40-16 outlines
the criteria for determining whether a debt restructuring should be treated as an extinguishment or a modification.<BR>
<BR>
According to ASC 470-50-40-6, a debtor should evaluate whether the terms of the amended debt are substantially different from the original
terms. The assessment includes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Present
                                            Value Test (ASC 470-50-40-10):</B> A modification is considered an extinguishment if the
                                            present value of the cash flows under the new terms differs by at least 10% from the original
                                            debt. This test involves discounting the cash flows of both the original and amended debt
                                            using the effective interest rate of the original debt.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lender
                                            Relationship (ASC 470-50-40-6):</B> If the amendment does not involve a change in lender
                                            or a legal defeasance of the original debt, it is more likely to be considered a modification.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
                                            in Payment Terms (ASC 470-50-40-8):</B> Significant changes in payment structure, including
                                            the timing of payments, extension of maturity, and introduction of new payment mechanisms,
                                            may indicate an extinguishment.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Additional
                                            Borrowings (ASC 470-50-40-15 and ASC 470-50-40-16):</B> If additional borrowings occur alongside
                                            modifications, the increase in principal is evaluated separately from the modification assessment.
                                            The incremental borrowings are treated as a new debt instrument.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Application
to the Loan Amendment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Present
                                            Value Test (ASC 470-50-40-10):</B> The core financial terms of the loan remain consistent,
                                            with the interest rate staying at WSJ Prime + 0.5%. The shift from monthly to quarterly payments
                                            and changes in the interest-only period do not result in a substantial change in the overall
                                            present value of cash flows exceeding the 10% threshold.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lender
                                            Relationship (ASC 470-50-40-6):</B> The lender remains the same, and there is no transfer
                                            of debt to a different creditor, supporting modification accounting.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
                                            in Payment Structure (ASC 470-50-40-8):</B> While payment frequency has changed, the overall
                                            economic structure of the loan is retained. The modification extends the interest-only period
                                            and changes payment timing but does not fundamentally alter the borrower&rsquo;s obligations.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal
                                            Increase (ASC 470-50-40-15 and ASC 470-50-40-16):</B> The increase in principal is attributable
                                            to additional borrowings rather than a fundamental change in terms. As per the guidance,
                                            these additional borrowings should be accounted for as a separate debt issuance rather than
                                            as part of the modification analysis.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conclusion</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the analysis under ASC 470-50-40-6 through ASC 470-50-40-16, the loan amendment should be accounted for as a modification rather than
an extinguishment. The primary factors supporting this conclusion are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            present value of cash flows does not exceed the 10% threshold under ASC 470-50-40-10.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            lender remains the same under ASC 470-50-40-6.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            changes in payment structure under ASC 470-50-40-8 do not result in a fundamental restructuring
                                            of the debt.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">The principal increase is due to additional borrowings, which are accounted for separately under ASC 470-50-40-15 and ASC 470-50-40-16.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Exhibit B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="exb_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MEMORANDUM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.75in"><B>To:</B></TD>
  <TD>Accounting files</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>&nbsp;</B></TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>From:</B></TD>
  <TD>Todd D. Macko, CFO</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>&nbsp;</B></TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>Date:</B></TD>
  <TD>March 6, 2025</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>&nbsp;</B></TD>
  <TD>&nbsp;</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>CC:</B></TD>
  <TD>Grassi</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>&nbsp;</B></TD>
  <TD>&nbsp;</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><B>Subject:</B></TD>
  <TD>Evaluation of Impact/DSS Loan Amendment Under ASC 480 and ASC 815</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conclusion
on ASC 480 vs. ASC 815 (with Non-Mandatory Stock Payment):</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
that repayment in stock is not mandatory in this loan agreement and considering the specifics of the payment options and the conversion
features, the loan would be accounted for under ASC 480 (Distinguishing Liabilities from Equity), rather than ASC 815 (Derivatives and
Hedging). Further,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASC
480 - Distinguishing Liabilities from Equity:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liability
                                            Classification</B>: The loan is primarily a debt instrument, as it includes a clear repayment
                                            schedule with interest payments based on the WSJ Prime Rate (which adjusts periodically).
                                            The Company (&ldquo;Borrower&rdquo;) has an obligation to repay the principal and interest,
                                            even if there is an option to settle in stock. Under ASC 480-10-25-14 (Distinguishing Liabilities
                                            from Equity), the standard provides that a financial instrument should be classified as liability
                                            if there is an obligation to transfer cash or other financial assets. In relation to ASC
                                            480-10-25-14 (a), which requires liability classification for an obligation to issue a variable
                                            number of shares provided that, at inception, the monetary value of the obligation is based
                                            solely or predominantly on a fixed dollar amount, we note that the first 12 months has a
                                            fixed $3 per share optional repayment method, however the Company deems this period to be
                                            insignificant and also covers interest only repayments, while the remaining period is to
                                            utilize a 10 day VWAP calculation until maturity introducing variability of shares into the
                                            repayment of the note. Regarding ASC 480-10-25-14 (b) and (c), the only variation to this
                                            optional repayment via Company shares is the fair value to the Company&rsquo;s share price.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Mandatory
                                            Stock Payment</B>: Since repayment in stock is optional and not a requirement, this prevents
                                            the instrument from being treated as equity. According to ASC 480-10-25-14, the mere presence
                                            of an equity settlement option does not change the liability classification. The non-mandatory
                                            option to settle in stock does not change the liability classification because the primary
                                            settlement method remains cash.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASC
815 - Derivatives and Hedging:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                            Derivative Instrument</B>: ASC 815 applies to derivatives&mdash;financial instruments whose
                                            value is derived from underlying assets or indices, such as options or futures contracts.
                                            To determine whether ASC 815 applies, we refer to ASC 815-15-25-1 (Embedded Derivatives),
                                            which provides guidance on evaluating whether a financial instrument contains an embedded
                                            derivative. Under ASC 815-15-25-1, an embedded derivative requires separate accounting if
                                            the embedded feature is not closely related to the host contract.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;In
this case:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9675;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            stock conversion feature is closely related to the host debt contract because it offers an
                                            alternative settlement method (stock) for the debt rather than creating a separate instrument
                                            that derives its value independently. Therefore, the conversion feature does not meet the
                                            criteria for an embedded derivative under ASC 815-15-25-1. As the note failed step A,
                                            steps B (the&nbsp;hybrid instrument&nbsp;is not remeasured at&nbsp;fair value&nbsp;under
                                            otherwise applicable generally accepted accounting principles (GAAP) with changes in fair
                                            value reported in earnings as they occur), and C (a separate instrument with the same terms
                                            as the embedded derivative would, pursuant to Section&nbsp;815-10-15, be a derivative instrument
                                            subject to the requirements of Subtopic&nbsp;815-10) were not tested.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
                                            the feature does not meet the definition of an embedded derivative, the loan does not qualify
                                            for derivative accounting under ASC 815.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
                                            Conversion Feature</B>: Since repayment in stock is non-mandatory, the conversion feature
                                            is not viewed as a derivative. ASC 815-15-25-1 specifies that an embedded derivative should
                                            be separated from the host contract if it is not closely related to the underlying debt agreement.
                                            The stock conversion feature is an embedded feature that is directly tied to the debt agreement
                                            and allows for stock payments as an alternative to cash payments. As such, it remains closely
                                            related to the debt and is not separated for accounting purposes under ASC 815.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;Conclusion:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
repayment in stock is not mandatory, the loan agreement should be accounted for under ASC 480 as a liability. The fixed $3 per share
optional repayment method for the first 12 months could lend to accounting under ASC 815, however the Company deems this period to be
immaterial in light of the fact that the remaining period is to utilize a 10-VWAP period until maturity introducing variability into
the repayment of the note. The non-mandatory stock payment provision means the loan is primarily a debt obligation, and the stock payment
is viewed as a secondary, optional settlement feature, not affecting the liability classification under ASC 480.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to accounting for this note under ASC 480, the Company elected to adopting the fair value option under ASC 825-10 and measured
the liability at fair value, which would be influenced by interest rate adjustments and the value of the Company&rsquo;s stock. However,
this would not convert the loan into an equity instrument, as the loan remains a liability with an optional equity settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Exhibit C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2020, and later amended, the Company executed a Revolving Promissory Note (&ldquo;Note&rdquo;) with DSS, a related party,
which accrues interest at a rate of 4.25% and is due in full at the maturity date of September 30, 2030. The Note was further amended
on July 24, 2024 with an effective date of September 16, 2024 to i) allow the Company to pay certain principal and/or interest payments
owing under the repayment terms in an exchange for potential of equity in the Company, ii) change the quarterly interest due dates to
the last day of each calendar quarter (i.e. December 31, March 31, June 30 and September 30), iii) to adjust the On Demand feature so
that it starts after the 24th month, iv) continue the planned repayment program commencing on the 37th month and on the last day of each
month thereafter through August 31, 2030 to pay a fixed monthly payment of $126,381, v) to continue the scheduled maturity date of September
30, 2030, and vi) adjusts the interest rate to be the WSJ Prime Rate plus 0.50%. As of December 31, 2024 and December 31, 2023 the outstanding
balance, inclusive of interest was $8,878,000 (net of change in fair value of the Note of $5,068,000) and $12,074,000, respectively.
The $8,878,000 is recorded in Note payable, related party at December 31, 2024. The $12,074,000 at December 31, 2023 is included in Current
portion of note payable, related party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for this Note as a liability under ASC 480, <I>Distinguishing Liabilities form Equity </I>(&ldquo;ASC 480&rdquo;). In
accordance with ASC 825-10, the carrying value of the Note will be recorded at fair value and will be remeasured at each reporting period
with the changes in fair value recognized in earnings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
considered various valuation methodologies in our analysis of the embedded derivative. Valuation methodologies can generally be
aggregated into the following three approaches: the Market Approach, the Income Approach, and the Cost Approach. Based on our
analysis of the facts and circumstances, in estimating the fair value of the Note payable, related party, we utilized a discounted
cash flow method (income approach), in the form of a Monte Carlo simulation of the Company&rsquo;s stock price and volume weighted
average price (&ldquo;VWAP&rdquo;) throughout 36-month period from the Effective Date relative to its closing stock price and VWAP
as of the Valuation Date, or $2.00 and $2.38, respectively. The simulated analysis estimates the expected note cash flow from the
date the first payment is due and until the equity conversion rights expire under the terms of the Note payable, related party based
on the following steps:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in">1)</TD>
  <TD>Developed the Note Payable repayment schedule</TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>2)</TD>
  <TD>Developed the following inputs underlying the simulation analysis</TD>
  </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="width: 0.75in">i)</TD>
  <TD>Stock price</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>ii)</TD>
  <TD>VWAP</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs
    (i) and (ii), were assigned a normal probability distribution, which has a mean of 0 and a standard deviation of 1, and a correlation
    of .9885 based on analysis of the guideline public companies</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ran
    a simulation with 25,000 trials for purposes of capturing the key inputs discussed above (i.e., forecasting the stock price and VWAP).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the period from the 37th payment to maturity date, the DCF Method includes the remaining payments required to be made in cash.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Captured
    the results of the simulation and concluded based on the simulation results</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>formcorresp_001.jpg
<TEXT>
begin 644 formcorresp_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !/ +T# 2(  A$! Q$!_\0
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M.&62">*.6-@5= P('Z[XA83@?&>''$&:\-8/A:M*E1P,J6-R?!97'$4'4S/
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MDJ52=*G)QE[]-RE3A)M;3C=M[.25]$MC_;#!(Z5P>@_"[X:^%O%OB/Q[X8\
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M^R&"($ O(YX502 3[U_6?%WBIF_ L>%LIR_+,MQU'$<'</8^57&3QL:L:E;
MX>BZ<5A:D(."5"+C=.;<G=VL?->'/B7FO%N7Y[6QF79=A99+Q/FW#U!866+:
MK8;*YJC1KUO;U9-5ZL8)U53M23;Y(I6/\CR+_@BM_P %6YY8H(OV$?CR99Y$
MAB$FA:1;QF21@B"2>XU>*W@3<1OFGECAC7+R.B L/]++_@DI^R_\0OV-_P#@
MGC^S'^SS\6&MT^)/@?P*9/&FG6=]%J5GH6O>(-4O_$%YX=MK^ M;WB:&=273
M9+BV9[:6X@F:VDD@,<C?<W_"R? ?_0WZ'_X'I2?\+'\!?]#=H7_@='7XWQQX
MH9YQU@,'EN/RW+\#AL)BWC?]BCC)U*U94)T(*<\5.?)3IPJ5&HTXISG).<K1
MC$^VQN95L;"%.I"G",).?N<UV[<JNY-Z)-[;]3\M_P#@O'\(?BA\=_\ @E=^
MT_\ "SX->!/$OQ+^(_BBS^'<?AWP7X0TV;5_$.LOI_Q1\':I?+8:?;@RW!M-
M.L[N]G"#Y+>WE<\+7^</_P .A_\ @I__ -&(?M*_^&VU3_XW7^N)%\1/ TTD
M<,/BO19)I76***.\5Y))'(5(T106=W8@*J@EB0 ":[+<3W/YFM>"?%7-^!<J
MKY3@LIR[&TL1CZN/E5QM7'4JL:E6A0H.G%8=Q@X*.'C)-KFO*2>EAX+,ZN"I
MRI0I4YJ4W-N;FFFXQC9<KM:T5YG^6!^PU^RG_P %F/V!OVF/AU^TQ\'OV'?V
MF!K?@W45MO$WAF7X?ZS!I'Q!\":B\</BCP/KR(A22RUBP#_8[AXY)-*U:*QU
M2VVS6JD_Z?WPL\='XI?#3P3\0+CPAXK\"2^,_#&EZY>^!O'VCS:)XO\ "EUJ
M-HDE]X<\3:1<J)+75-+N&FL;Q"&AE:(RPM)!(C-TVO>)=#\,61U#7]5MM,M<
MD(UQ)B29AR4MX%W33OZK$C8ZL0.:\1U+]I3P7;2,EAINN:J%)'FK#!9H^#U3
M[3+N*D<JQ R.PZ5Y7&_'&)X]KX+&8O(LNR_'8.$Z#QN JXR53$X9OGIX?$K$
MODFJ%1RG0J)^TIJI4I7=*2C'/&XUXV49SHTZ<XKEYX.=Y1Z*2EH^5[/=)M;'
MIOPV^&7@/X0>$;'P#\-/#.F^#O!FE7>KWFE>&]'B^SZ5I<FN:K>:WJ4>GVH)
M2UMI]4O[R[%M%B&*2XD6)4CVHOYH_&[_ ()DW_Q>_P""J7[*_P#P4BB^+EKH
M=C^S?X \1^"I_A2_A:6]NO%3Z]H7CG1EOXO$ZZK!%IB6Y\8BX:!M+NS)]@\L
M2IYQ*?J1X4\0P>+/#NE^(K:VFLX-4@-Q';7#QO-"H=DVR/$3&QRI/RG&".]?
MSK?\%*?^"AO_  4)^&?_  5!_9>_X)[_ +%5]^SQHUQ^T1\+-1\46VM_'#P1
MXB\1VMAXBTA/&6KWS7&H:#XGTB>#3GT3PE-#;VT6GW,IOYHR92CE5\SA6CGN
M/S;,*64XW#8;&5\ESUYCB\SK1C1_LMX)_P!L2K5ZU#&24YX7F;J1ISK74I0G
MSZO+#JM.K-4YQ4W2K.<IR5O9\EZK<FI;QN[V;ZIW/M'_ (*0_P#!+J^_;5^,
M7[)/[3/PD^,,'[/O[1W[)/CP>)/#'Q!;PM-XH@\2^%9+NUU&Z\$:U96NL:+-
M_9MQ?6TB22BXEWZ?JFL6+1F*^>LO]O?_ (),P?M3_&SX5_ME_L__ !X\1?LD
M?MR?![1D\/:%\:_".A6OB+P_XQ\.A+E#X8^(?@^\NK0:WH\2:CJEM"R7J3RZ
M7?3Z1?B\M/LIL\#X53_\%NOAUJWB_P >_M:_$']A;Q#\&/!OPH^*?B?4-+^#
M_@#XAZ7XVG\4Z%X+U35?!QMKG7?$5UIYTM-<M(&UB"2-);BP\R*&2*1UD3\U
M_P#@GA^V-_P7P_X*1_L^S_M&_"'XB_\ !/CP=X13XA>+OAXFC>.?A!\3/[=_
MM'PD-,>[NV.C^.KJS^RSIJMNL'[P2EHY2Z*-I/T^ PW$]#"T<7A.*N%UEW#%
M/^RJ>.GCZ=;!1H\23Q>(JY-6E6R*J\PPN(EA<1.K@,7A:N&HJI^[E!U;PWA'
M$*//#$4.3#VIJ;FG"U=RDZ3O2?M(2Y)-PE%Q7S/M+P__ ,$:_C=^T!^T-\)O
MVA?^"H_[9S?M@+\ -8B\1?![X(>!?A9I_P '_@GI?B:*2TN8_$GB;P]%JVMW
M>O:@MYIVG7,\+3PQ7QM(+>Y<V22VESW_ ,:/^"6?[4>A_M._$G]J[]@S_@H5
M\1/V>/%GQEF@N?B9\)_C!X<G_:#^"5]>6\EQ<)=^&?#7B+7[.^\*0B[O+NYM
MM*TJ[BT[37N;B*P2&RF^QI\N_P#!3+]O?_@I_P#\$W/V'/V;O&7CK7_V6?%?
M[57Q6_:LB^$/BC6O#7P\\6S?"2/P+XAT#Q7J?ADZ9X?U'Q78ZW:Z[:7&E:;_
M &M?2:G<02QBY2"T!='34_:+^+W_  <"?LC_  $\=_M3^-/&_P#P3C^+_P /
MOA#X1N?B/XY\!^'_  #\4_ GB'4/!VD6:ZEK8TK7]7\6WEB-2MK(2&"T2-I[
M^51;V/F7,L$;]5"EQ=BHY=C%G_"$,)F$\PX<R;+J_P#9]/)\?3PN/PRQ.'P.
M53X?J9>J.(S+$X6K#$U%A*]?$U*=:IB8M)0:CB9*E+VN'Y9\]"C!N'))1E&,
ME"FZ+A[TY1:EI*4FI-KIZ[\+/^"+?C?Q_P#M0Z'^V3_P4B_:VUS]KWXS>!?!
MWB#P-\+/#_@CP9#\#?AE\.=)\1Z?J>G7=_H>G^']6O?$D>KVL>MZO?:9=6^N
M6;V&NW,6N0RF\L[,6_.^!O\ @E3_ ,%)/V5U\2^"/V*?^"KFK:/\$=>UW5]?
MTOP;^U+\%[7]H+Q=X,N=<N9+B\@T+Q[>^)M*U2YBC+IL?44D\Z:(74D<<\MP
MTWS-^VK_ ,%UOCUI7_!,W]AS]M[]D_P?X#\#^,OVHOBG#\./%WA/XL:#J7C?
M1?#.I6T.HZ9K%KI%SI^K^%YKRQC\06#7%AJ[$M/I4D<<UK'=+*%^W?#?@[_@
MXC3Q#X>E\4_&G_@FO<>%UUK1Y/$MOI'PF^+<.JS^'Q?VS:U!ID\_BZ2WBU&3
M3?M4=E-*KPI=&)W#1@Y=?_7/#X58G.<VX4R_"5:N.R>ADN=T,K>$I3X:Q=2C
M7H8'*89%C<'A?JV+Q-1TZN&KT7B)XJ52I4KJJW%R6*C%2JU,/"+<Z4:57V?*
MGAY)24*?LI1C:3T<6G)R;;?,SVK_ ()N_P#!*CPQ^PCXS^.7Q^\<?&/Q?^TG
M^UG^TS?QW_QG^-_B[3]/\/I?PK?_ -KRZ'X9\,:3FSTC2;C6,:C=//-=74[P
M64"O;VME# /UHK^1/]KW_@O]^T1^Q;_P5T^*'[/OQ'\"^#O$7[!7PF\2_"+P
MQ\1/$^@>#-;/Q$\!67Q6^&7@[7(/%NI>*X=;N=+N(M+\5Z[>W,.D3Z#:MJ^D
M02Z99W#:E'"\OZS?MR?M^?$/X,?'[_@E'X1^ FK?#SQ1\)_VY/VA[+P%XV\1
MWNF3>(SJWPXU71=(U?2]5\":Q8ZO8VVG75[;ZD+B#4IK?5(6B>+_ $7AL^%G
MG#/&&/QV4YAF\J&)K<29.\TP&,C7HK"+!9?E%3'K -8?#TZ& KX+*\+!4LMC
M0IQITI8=4N:E-UEE7P^*E.G4JVD\12]I"2E'EY(T^90]U)0E&FE:G96C:UUJ
M?L-17\['[0O_  4U_;$^/W_!0[Q;_P $T?\ @F#X?^#FF>+_ ()^'SXD_:/_
M &DOCMI^M>)O!7P_DA?3H+SPUH?@_0KW3;G5M1L;S6]*TFY>:Z>XN-7FN8;6
MT2QTZ[O3WW[,/[</_!0KX4?MV:=_P3]_X*(_"[P)XXN?B9X)U?QU\#?VM?V<
M?!?C'2?A=K:Z/9ZA=W7AWX@Z)J3ZS;>#[EET75+6WO+[5+$KJD=E9O;W$&LV
M%RGE3X,S>G@UB:E7+*>)>4QSY9/4S&E#.7D\HJK''?4ITXQY98=K%QPWUOZ]
M+!OZS'!RIV3R>&JJ-WR)^R5;D<XJI[-[2Y7;5Q]]1OS<GO6Z'[TT5_(U^PU^
MWK_P7&_X*.:G^T[J/[/_ (Y_8/\ !'A;]GSXZZ]\(Y;/XF?"3XB3ZQJ*6]SJ
M=QI=Y!/H/CF:WE6+3+6WANY98[=YKMI)(HEC^5?Z&_V+M)_;NTCP1XJA_;V\
M7_L_>,/B#+XE23P=>?L]>&/$_A?PY:^$_P"SX5DMM;M?%.J:K=W.L'4A/(D]
MO)%;BU:.,HTBLYC/>%,5P[*O1Q^:9#/&X9X>-;+<)F-3$8^#Q-*C7A>C_9U&
MG:%'$4:E6V*?)&:MSM.**V&E0<HSJ4>>/+>$:G--<RC):<BV4DWKIYGV5111
M7RQSG\_OP8_Y2F>+!_U47XHG/;_CUO./K7[>_%S_ ))GXT_[ D__ *,BK\0O
M@Q_RE,\6<<?\+%^*/.>_V6\X_K7[O>,- ;Q3X8UOPZMR+-M7L9+,731F80%V
M1O,,09"X&W&T,O7K7[)XQNV:\&M[+@'AAOT5"+/Q/P/_ .15QM_V<;BG_P!2
M9'Y=8'H/R%&!Z#\A7U=_PR]<_P#0Y0?^">3_ .3*RM=_9QN-$T75M8/BR&X&
MEZ=>:@;<:4\9F%I \WE"0W;;-^S;NVMMSG!K\M5>DVDIZMI+W9;O3MYG[897
M[.WA2VUKQ5>:[>PI+;^&[>.2V1T#1MJ5V62"0@C!:VB22100</)&ZX9 :^T-
M=UBUT#1]3UN^;%KIEG/>3<@%Q$A*Q*3QOFDV1)G^-QFOF[]E^:$Z5XMMP1]H
M&I:?<$<;OL[6AC4^N/,5N.1GG.>*]7^,T%Q<?#+Q6EL&+K9PRNJ9+-##=P/*
M,#J%4;V_V5)/ -<M:\J_*]N:$5Y)\M_ONP/@OQ;XLU?QIK-SK6L3O))*[?9;
M;<WV?3[;)\JUMHR=L:1KPS ;I'+.Y9F)KFJ.O2BN])))))):)+9 ?H[\'?\
MDF?A'_L''_T?+7\B7_!6_P""7AC]I+_@XF_X)T? SQ=XK\?>#-!\?_ OQ'8Z
MCXB^%?BZ;P-\0]*CT[2OBSK]O-X;\46T%U<Z1<3W>CQ6MU-%;2&XTV:^L\ 3
MLZ_UV_!W_DF?A'_L''_T?+6?\3=7^!7PVBB^,GQAO/A7X*7PK$UM:_$_X@MX
M6T2XT&.:*Y_T.P\6ZZ(+FQ:XA>[5+.SO4DG22X1(G#N#ZG"N?UN'<XQ>-PV&
MKXG%8G*\ZRG"QPTDJU+$YIA986AB:<7A\5[66&J<M54%0J2JN/(D[M/HPU:5
M"HYQBY2E2JTXVW4JD.126DKN+U2L[[6/S^^'/_!/#X5?L,? G]K;4?AU\7/V
MF?B9)\0/@?XYMM5C_:"^,VH_%2TTB/0_!?B62"3PW#?Z7IRZ-+<&Z<7\L9E-
MTD<(;;Y?/\9O_!(ZW_X(W7_[)=W+^W%^W3\6/V?OC8_Q:^("?\(!X&^/'Q)^
M'NB_\(<5T;_A']=7P_X2\/ZKI'VO4Y&U)9[\77VJY%K$LT2+#&6_T$O@[^TU
M^S3^TO8ZLOP.^-OPD^--G90S0ZY9^!?&?AWQ<UO:2XMYQJ>G:?>74Z64WFBW
MD>YMQ:RF0PEF+%:Y/XH:%^Q-\$M%L_$GQB\,?LR?"_0=2U%=)T_6/'GAGX:>
M%].O]5D@FNQI]I=ZQI]K%<WK6]O/<FWA9Y?)BEE*[$9A]%DW&69Y=2SO+,UH
M\25,WSG'Y1BI8K+JF%P&:T_[,PV+HQPTL+C,AQ"J0KT\1&34,OIS4*,6I2]Z
M;Z*>+K4U6IS5;VU:I2DY*T:B]G&:47!T7?F4O^?:T77<_E!_X+\_%S]F/X\?
M\$O?^"?EQ^RG\96^+WP1\._MK^ ?@]HWQ(M=;U;4-;EN?"GPV\8Z+?"\\0:[
M8:?J=YXHTZVE@NY]7GL]\EZR7OSDFLW_ (+;_P#!*[6OV7_V,?!G[1_P]_:2
M_;>_:0^$WP]\?_#[4?VG/@?^T#^T=XG^(7A3Q'\)=6NM,MC?:59Z;8>''T==
M)UDV>FW\H>[DAL-<CU"*6R71Y)G_ +'-!\$? ?Q9X#\.S>&O!?PE\0_#.[%O
MXV\*?V/X8\):GX)F:^MOM%KXKT&*UL9=&,MU:2^;%K5@GFS0/N6X9&R?$=?_
M &Y/V![ZTU3POXH_:B_9DOK"47.D:SX>UWXF^ +NQF2"5K:[TW4=*O\ 4I+>
M6.*:)H)[6X@9%>,QNF5P.O*..\SR]9'A,ERK-<1A<ASK.<PS##U84L;7S"AG
M&+IU7A\34PV25:F!QE!0Q:ABZ#P36*=*M3IQEAI03HXRM3]C&E"I*-&I5G./
M*I.:JR3:DU2DX25I6E%P:=FM5I_*G_P<#:U^S'K7_!)O_@F!KG[-=AH/@C]E
M_7?BQX&U+X>:1X8G\BQ\+>"[WP?<W6HZ?'<QRW,YUG09VU6#7+N2:[OSKUGJ
M-Q=SW%YYLK_4?[+_ ,5_^#>O]GOXY_#SXK_#'_@IO\5?%7C_ ,/ZB]CX:\/?
M$+]H7XO>-?".IZEXDLI?#T=IJOAG5/"46GZB6_M(K:K<RI%;7GDW&Y?)##^E
MCP8?V7_C/X#L(O $7P)^*?PS\/3&33;3PM;>!/&7@OP]<R)).YM+'38]0TC1
M;F2-Y9G6."UF97DD((=B?*_AEXA_X)[_ !;\43^%OA%/^R1\0/&.DV\NK3Z#
MX&L?A5KWB"PM=/N8H9M1:PTFUGOH(K*[>%);D1JMM.T89T<KG&/%T99!+(JN
M!XNI4,#C.(,1C:N#Q^$4JU#/<8L1&GG4L=D.-JJK1A%4JF(E6P3Q,YUZNDJB
MY)>)G['V*C7C&$ZTJC33;5::E:HY4I--)6YG*',W=GX+?##]GGX3_M<_\%KO
M^"[?[.7QFT6V\3?#KXH_L[?LQ:+KNGED^V6$D_PX^&UQHOB+29AF33]=\/WS
MVFM:)?IAK:]MX'97B>2*3\7O ^D?M7?L??\ !3W_ ()D?\$JOVE+F7Q;X%_9
M=_;LT#XB?LN?%*^,RR^*/@K\2)GM-/L-,GEW176BVU[8AXM.$K7/A;73KOAT
MJMG!8PP?WJ?$GXQ_LL_L]>)H]:^*WQ"^"7P<\9^/;!Y%U?QCK?A#P9XG\8:7
MH/V2T9Y=0U&6QU36[#2-]E;*99KB"S'V>%/+"HHS_BI\8OV1? TWP[\?_&GQ
M_P# 7PS=ZS:2ZM\*O&?Q$U?P787M]8VRV5_+J/@;7]>=+EK>!=3L+QKG1;H+
M']NMIRP\^-FZ,OX\Q]%SI2R#%X_+,?P[@LJP.%E&O.5#.<JX;Q/#RSS*Z\,%
M.+G+#8G$PQN&H*I[7!N-&O/GH4ZL+CC*BO'V$ITZE"G3A%J3<:M*@Z/MJ;4?
MB<7)2BKIQ:4OA3/Y7/AU\4_"O_!'G_@O;^VWXV_;/GO?AQ^SU^WGI>H>,/A%
M^T#J6DZI=> 8-5O=?T_Q2N@:UKEK:W*V<NGRQZ]H6L*%>>RU&#1KBX@33+Z.
M]'Z[_!G_ (+(>%_VQ?V]]$_9<_8D^&MI^T1^SIH'P_UCQ'\?_P!L+3M5US1O
M!'PRU==/U&YTCPWX:2Y\,26'C&YU*Z_L33/*.L:1<M>ZC?36D%W8Z3/<R?=M
M_P#M._\ !/OX_7>B_##5OC9^RS\8KWQ1JUIH_A[P+JGB_P"'7C>?6]<U*5+:
MRT_2-!O;K4&N]3O9FC@MH;2W:XFD*I&"Q KUKX0>)OV9[/6/%_P<^!&J_!NP
MUWX=RQ1^.OAM\,'\*6&H>$)Y))+6$>)O#7AQ89M*F>5)(%;4;6*1W5TR6#"O
M*S?.<'F-&.,S?A3-7G]#AW!Y.Z]:OB<-D\8X"A2RO!9W/!/+Z&-CB:.'IT:2
MHRQBRRICE&I4<^9X2>56K&:4JN'J>UC0C2NW*-/W$J<*KCR*5U&RMS<CFDV_
MLG^>[_P32C_X)7WOB7]N+_AX#^V-\2?V;/%\?[5/B]?A]H7@'XS>//AI:>)O
M"YU#73J&L7^G^#-%U:VU2YM-5WV27M[)%<01%((U,;;C_<I_P36^,O[%?Q&_
M9WTWX?\ [#GQ^N?VAOA?\#+I_!=_XKUCQ-XB\8^*K+4]8N;[Q/'9>*/$OB?3
M-+U/5K^1-1FDMKAX'5+!+>W#[85%?2VH_"3]F>&XUB?5OAA\!XKK3DBU+Q!+
MJ/@OX?QW%@FI22/#J&LR76G"6U2_E$K17=\8UNI!(4DD;=75>&;3X/> M5;P
M1X,M?AGX*US5XUUA_"'A>'PMX<U;5(EC94U1O#^E"SO+Z-8E94OC:2J(PP67
M:#3XQXPH<6*K46'XAH3<\+7H8.OC\NQ.485X;!X;"5:E*C1R:ACK3H4G.,IX
MZ<:<J\I3O3Y+&*Q3Q+;:J)>ZXP<HN$7&$(-JU-2U46_B?Q:Z'I%%%%?G)Q'\
M_OP8_P"4IGBST_X6-\4?S^RWGO\ Y_2OW9\<:S=^'O"'B+7+ 1&]TO3)[NV$
MZ>9#YL>W;YB9&Y>3D9%?DQ\+_P!FSXU:#_P4"\1?%_5?!JVOPZO/&WQ U.V\
M0?\ "1^%9S)9:O!=)I\_]D6VM2ZVGVAG4>5)IR2PYS-'& 37ZO\ Q"TZ]U?P
M1XHTO3H?M%]?:1<6]K!YD4/FS/MV)YL[QPQYQ]Z215'<U^L^+&/P&89GPE/
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M-D@9.X\GU/)YK]'OA'X+_P""_MI\5?AQ=_&KXT?L":K\';;QMX>G^*6E>"_
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J*=2IQSK58-TU4@TH\G/32M*/+&+2E9-IQC&+?*F[/:[N=:***^4.<__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exa_001.jpg
<TEXT>
begin 644 exa_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ") 2P# 2(  A$! Q$!_\0
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M$\7B!94\DPSQ %DW;@0>X-2>*[*WN] NGGC#M!&TD9S]UL=:R_A_80Q:.U\
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M,E<F!PNK;4%\SH,@DC(R.U+7AD-[=6]P+B*XE28'(<,<YKV71KU]1T:TNY
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M&VO_ %Q3^0JS5;3_ /D&VO\ UQ3^0JS7-+XF=]/X%Z+\D<1XP_Y&C0O]\?\
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MT_A];?\ Y"G]HQFWV_?"?QGZ8ZUGPK=/??$-;'=]J(01[>N?*/3WI*G%QO\
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5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>exb_001.jpg
<TEXT>
begin 644 exb_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ") 2P# 2(  A$! Q$!_\0
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M$\7B!94\DPSQ %DW;@0>X-2>*[*WN] NGGC#M!&TD9S]UL=:R_A_80Q:.U\
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M,E<F!PNK;4%\SH,@DC(R.U+7AD-[=6]P+B*XE28'(<,<YKV71KU]1T:TNY
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M&VO_ %Q3^0JS5;3_ /D&VO\ UQ3^0JS7-+XF=]/X%Z+\D<1XP_Y&C0O]\?\
MH8KMZXCQA_R-&A?[X_\ 0Q7;UU5_X5+T?YGFX+_><1ZK_P!)*FJ?\@B]_P"N
M#_\ H)K ^'__ "+9_P"N[?TKHKZ)Y]/N88QEY(F51[D$5D>#]-NM+T(07<?E
MRF1FVY!P./3Z5,9+ZO)7UNOU-*D)/'4YI:*,M?FC.^(5K/-I-O-$K-'#(3(!
MV!& ?\^M>;Q1//*L42%Y'.%51DDU[N0&4JP!!X(/>JMOI=A:S&6WLX(I#_$D
M8!KJPV/]C3Y'&YYV89)];Q'ME.U[7^78?8120:?;0RMND2)58^I YJQ17">-
M/$6I:?JD=G9RF",1ARP RY.?7M7%1HRKU.6.YZN*Q5/!4?:3NTK([NBL;POJ
M=QJVA175TH$N2I8# ;'>MFLYP<).+W1T4:L:M.-2.S5PHHHJ#4**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ IDT,=Q \,R!XW4JRGH13Z*-A-)J
MS.)F^'-J]QNAOI8X2?N%0Q'T-=3I6E6NCV2VMHA" Y9CR6/J:NT5O4Q-6HN6
M<KHXZ& PV'FYTH)-GF?C/Q%=7&HSZ9#(8[6(['"]9#WS[>U2:'XG72-.TJT7
M:ZO*YN!W52V!^/>CQ?X8O5U2:_M(7G@F.Y@@RR-WX]*H>'_"M_?ZA$\]O)!:
MQL&=Y%VYQV ->W%8=X97:LOSL?(SECXX^7*GS-V7:UT_2UOUZGJ]<3\0[ZW_
M +.AL1(IN#('* \JN#R?SKMJ\2UD3_VU>_:<^=YS;L_7_"O/RZDIU>9OX=3W
M,^Q3HX;D2^/3T/8].=6T^W4,"RQ)N /(^4=:M5YYX FN[C6;R5W9XS"!(3TS
MD!?TS7H=<V)I>RJ.-[GH9?B?K.'52UNGW:'!>++N&7Q?I,*2!G@=?,Q_"2P.
M*[Q6#*&4@J1D$'@UPFN>"+V]UN6[M)XA%.^]MY(*'O\ 6NST^T%AI]O:!RXA
M0)N/?%:XETW2IJ$KM+_@G+@(XA8FLZL+)NZ?II^6I9HHHKA/9"BBB@ JG?Z5
M8:F$%[:QS;/NEAR/QJY13C)Q=TR9PC-<LE=#(H8X(EBA14C0855& !3Z**0T
MDE9!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K+U+P[I>K2"6[M0T@&-ZDJ2/<CK6I151G*#O%V9G4I0JQY9I->95
ML-.M-,M_(LX%BCSD@=SZD]ZM444FVW=E1C&*48JR04444B@HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#FO'FI7VC>$KO4M/N3#<6Y4CY%
M8-E@N""/>KQU2/2/#$>IZE.\B1PI)-+M&3NQS@8'4UC_ !/_ .2>:I](_P#T
M8M)XFC2Z\&:9ITGW+Z:TMF'J"5)_05O&*<8W[F+;4GZ'71R)+&DD;!D<!E8=
M"#T-4[#5[34Y;V.T<R&SF,$N.F\ $@?G7#:;K%[H%M?>$"2^J0RB+2V8?ZR&
M0G:WT09S]*O^!["/1/$'B31XG9DBD@E4N<LVZ/EC[D@TG3LF_N&JEVD:7_"<
M6 6^=K+41%82F*ZD$ 81,.N<$DCW%:-_XCTO3M+MM2GN1]DN7C2*1>0V_H?I
MWKD]"M+R_NO&5G:RPPK/J;QR2.I8JI0 [1T)QZU%JNBMK%V?#^GVB7&G:18_
M9OWDVS;.Z_*V<')50#]6J^2%[?UL3SRM<]!N;F"SM9+FYE2*")2[R,<!0.]9
M,?B/[1;?:K72-2FM\95Q$JEQZJK,&/Y5PNH:Q<W_ ,-+?[4C/+IE]%!JL?4[
M(VY)'H?E->H6UQ#=VT=Q;2+)#(H9'0Y!!]*SE#D6I<9<ST,.W\7VEY#!+:6&
MI7"2HS_N[8_)ABN&R>#D'CVIEIXUL;ZV2YMK'4I+9Y?*\X6WRAMVWGGC!ZUO
M6[6[PM]F,90,P/EXQNSST[YS7*?#+_D34_Z^I_\ T8:+1Y6[!>5TKG57H<V4
MWE2M$X0E74 D$?7BO-K3Q/X@3P)'XI?4%GDCN"DMH\*A)%W[,*0 0WXUZ7=?
M\><W_7-OY5Y)X<\--J7P[BU.VOKB&]LYI;B!&?=#N1B1E#QVZU=)1Y;R[HBI
M>^G9GI5[X@MK"]T^TG@N/.OSMAVID;L9()SQ@<TZ_P!=M;*\6Q2.:ZOF7>+>
MW7<P7^\W0*/<D5Q@UB37Y/ .J31B.6XGE+J.F0A!Q[<5J^%W%OXS\46MW\M]
M+<)/$6ZO!MPNWV'/YTG326O3_.PU-MZ?UI<V+?Q) VHQ:?>VMSI]S-GR5N%&
MV4CLK D$^W6LKQ!XM.A>--&TZ8@65Y&PE)'W6+ (<_7C\:/B1L/A,JO-Z;B+
M[$%^]YV\8V_AFLS6]$;Q1KVLV,V!/#I,*1L/X92S."/Q7]:<(Q?O/;7^OQ%.
M4MEN=_+*D$+S2L%CC4LS'H .2:Y?P3XGD\3:?J5XRDB.[=88P "(\#:/J?ZU
M@V&OS>+/#FF^'W9EU&:0V^HC^*.*+[Y/INX'XFM3P9''9>*?%E@@"JMU'*B@
M8 5DX_E0Z?+&2>__  1\_-)6V-"U\:6E[&\MOINIO%'<?9Y'$ (1\@$'YNQ/
M6IY?%5LFKW.E)87\UY;J'=(H@1M/1@<XP:Y?P7!JSV&J2V.H06\*ZQ,9(Y(<
MY4,-WS9XX]JU=-_Y*QK7_8.@_F:)0BFUV_X E*32\_\ @FSIWB73]0O389FM
M;X#=]ENHS'(1Z@'AA]":DT[7K74]2OK"&.=9K%@L^]0%4GD8.><CFN=^($4<
MT_A];?\ Y"G]HQFWV_?"?QGZ8ZUGPK=/??$-;'=]J(01[>N?*/3WI*G%QO\
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5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
